Rare Influenza A (H3N2) Variants with Reduced Sensitivity to Antiviral Drugs
Open Access
- 1 March 2010
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 16 (3) , 493-496
- https://doi.org/10.3201/eid1603.091321
Abstract
In 2007 and 2008 in Myanmar, we detected influenza viruses A (H3N2) that exhibited reduced sensitivity to both zanamivir and amantadine. These rare and naturally occurring viruses harbored a novel Q136K mutation in neuraminidase and S31N mutation in M2.Keywords
This publication has 13 references indexed in Scilit:
- Host cell selection of influenza neuraminidase variants: Implications for drug resistance monitoring in A(H1N1) virusesAntiviral Research, 2010
- Rapid and Specific Detection of Amantadine-Resistant Influenza A Viruses with a Ser31Asn Mutation by the Cycling Probe MethodJournal of Clinical Microbiology, 2010
- Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase MutationJournal of Virology, 2009
- Epidemiology of Human Influenza A and B Viruses in Myanmar from 2005 to 2007Intervirology, 2009
- Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South AfricaAntiviral Research, 2009
- Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996–2007Antiviral Therapy, 2008
- Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005Antiviral Research, 2007
- Amantadine-Resistant Influenza A (H3N2) Virus in Japan, 2005–2006New England Journal of Medicine, 2007
- Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and OseltamivirAntimicrobial Agents and Chemotherapy, 2003
- Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B VirusThe Journal of Infectious Diseases, 1998